Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial–mesenchymal transition in triple-negative breast cancer
Context Tabersonine has been investigated for its role in modulating inflammation-associated pathways in various diseases. However, its regulatory effects on triple-negative breast cancer (TNBC) have not yet been fully elucidated.Objective This study uncovers the anticancer properties of tabersonine...
| Autori principali: | , , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Taylor & Francis Group
2024-12-01
|
| Serie: | Pharmaceutical Biology |
| Soggetti: | |
| Accesso online: | https://www.tandfonline.com/doi/10.1080/13880209.2024.2351934 |